| NEW YORK and YANTAI, China, Nov. 14, 2011 (GLOBE NEWSWIRE) -- Bohai Pharmaceuticals Group, Inc. (OTCBB:BOPH) (OTCQB:BOPH), a China-based pharmaceutical company engaged in the production, manufacturing and distribution of modernized traditional Chinese medicine (TCM) in China, today reported financial results for the three months ended September 30, 2011. Fiscal First Quarter 2012 Financial Highlights: Revenue increased 78.3% to $29.9 million for the first quarter of fiscal 2012 from $16.8 milli...continued BOPH |
Monday, November 14, 2011
Bohai Pharmaceuticals Group Reports 78.3% Increase in Revenue for the Fiscal First Quarter of 2012
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment